Streamex Corp 8-K, filed Apr 30, 2021
Streamex Corp. (STEX)
About this 8-K
Streamex Corp filed this 8-K on April 30, 2021, reporting on events of April 28, 2021.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| | | |
| (State or other jurisdiction | (Commission File Number) | (IRS Employer |
| of incorporation) | Identification No.) |
| | | |
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
|
N/A (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||
| | | The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 28, 2021, Andrew L. Filler informed BioSig Technologies, Inc. (the “Company”) that he will not stand for re-election to the board of directors of the Company (the “Board”) at the Company’s 2021 Annual Meeting of Stockholders (the “2021 Annual Meeting), which is scheduled to be held on June 28, 2021, and will retire from the Board upon the expiration of his term at the 2021 Annual Meeting. Mr. Filler’s decision to retire was not in connection with any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.
On April 28, 2021, Martha Pease informed the Company that she will not stand for re-election to the Board at the 2021 Annual Meeting and will retire from the Board upon the expiration of her term at the 2021 Annual Meeting. Ms. Pease’s decision to retire was not in connection with any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.
Upon the retirement of Mr. Filler and Ms. Pease, the Board has determined to reduce the size of the Board to seven, which it believes is an appropriate size for a company with its market capitalization.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BIOSIG TECHNOLOGIES, INC. |
|||
|
Date: April 30, 2021 |
By: |
/s/ Kenneth L. Londoner |
|
|
Name: Kenneth L. Londoner |
|||
|
Title: Executive Chairman |
|||